This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 203 Users Online

Miscarriage Analysis Market

Miscarriage Analysis market - Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029

Miscarriage Analysis market Segmented By Test such as Cytogenic analysis, Chromosomal microarray based analysis (CMA), Blood Test, Pelvic Ultrasound scan, Cervical weakness testing and Pre implantation genetic diagnosis

Market Overview

Miscarriage is referred to as spontaneous ending of a pregnancy. About half of the miscarriage appear within the first trimester earlier than 20 week’s gestation. Recurrent miscarriage remains to be challenging reproductive problem for the patient and clinician.

The statistical data demonstrates an expected 1 out of 4 pregnancies end in premature delivery, around 1 of every 100 ladies in the UK experience recurrent miscarriage, more than 6 out of 10 of women who have a recurrent miscarriage proceed to have successful pregnancy. Many miscarriage in the first trimester are caused by chromosomal abnormalities in the baby.

Miscarriage analysis testing, additionally called Products of Conception testing, is a subset of the general pre-birth testing market. It permits obstetrician and gynecologist, physicians, conceptive endocrinologists, fertility specialists and clinicians to more readily decide whether there is a hereditary reason for miscarriage or other related event.

Identification of cytogenetic factors for the miscarriage in the assessment of couples with history of recurrent miscarriage give rise in growth of miscarriage analysis market. Other critical factors are identification of antibodies, uterine abnormalities, hormonal & metabolic factors and infections are the important component for the growth of miscarriage analysis test market.

Increase in the risk factors for miscarriage includes previous miscarriage history, exposure to smoke, obesity, thyroid problems, diabetes, drug or alcohol use are the contributing factors in the growth of miscarriage analysis market. The other most common cause of miscarriage is chromosomal abnormality and other causes included hormonal changes, change in life style, maternal age, maternal trauma etc. are expected  to be driving force in growth of miscarriage analysis market.

Careful assessment through miscarriage analysis with an examination of cytogenetic factor, restorative history and physical examination, ultrasonography and serum beta HCG testing can be useful in making a very certain diagnosis.

Not just cytogenetic of miscarriage analysis been demonstrated to be financially effective in the medicinal services framework but the outcomes help the gynecologist to choose for further examinations, bringing about time-investment funds to both the patient and the clinician, as well as cost-savings to the health care system.

Different reimbursement policy for the different types of miscarriage analysis test as conventional chromosomal analysis cannot be covered due to policy constraints could be a restraining factor for the growth of miscarriage analysis market.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Market Segmentation

  • Cytogenic analysis
    • Karyotyping
    • Chorionic villi (CV) sampling
  • Chromosomal microarray based analysis (CMA)
    • SNP based CMA
  • Blood Test
    • Antiphospholipid syndrome (APS)
    • Thrombophilia
  • Pelvic Ultrasound scan
    • Hysteroscopy
    • Laproscopy
    • 3D scan
  • Cervical weakness testing
  • Pre implantation genetic diagnosis
  • Other
    • Hormonal and metabolic factors
    • Infection
    • Male factor
End User
  • Obstetrician and Gynecologists Center
  • Endocrinologist
  • Hospitals
  • Specialized Clinics
Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Regional Outlook

The miscarriage analysis market is expected to be dominated by the North America due to higher prevalence of the clinical miscarriage case, increases awareness of miscarriage diagnosis, access to abortion providers and availability of information and healthcare. Europe is expected to be the second most lucrative region in the miscarriage analysis market.

Asia-Pacific is expected to be the fast growing miscarriage analysis market due to large population residing in countries such as India and China with attributes like shift in the economy and in attitude about preventive measures in the pregnancy care.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Key Players

The key participants operating in the miscarriage analysis market are Igenomix, Natera, Integrated genetics, Invitae, VCGS, Quest diagnostics, MedlinePlus, Genomic diagnostics, Leeds Genetic Laboratory, Labassure and others.

Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Conect me to identify wining opportunities

Ask An Expert
I'm Available

The report covers exhaustive analysis on:

  • Miscarriage analysis Market Segments
  • Miscarriage analysis Market Dynamics
  • Historical Actual Market Size, 2013 - 2017
  • Miscarriage analysis Market Size & Forecast 2018 to 2024
  • Miscarriage analysis market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Miscarriage analysis Market Drivers and Restraints 

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance 

- Companies Covered in This Report -

Google translate